David Allan Watters

David Allan Watters

Auto-generated profile, based on publicly available information

David Allan Watters

School of Medicine and Health Sciences Deakin University Geelong Australia

Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2012 in International Psychogeriatrics
Verified
Journal Article
Open access
PDF file
EMEileen Moore
Eileen Moore
AMAlastair Mander
Alastair Mander
DADavid Ames
David Ames
RCRoss Carne
Ross Carne
KSKerrie Sanders
Kerrie Sanders
DWDavid Watters
David Watters
Background: This review examines the associations between low vitamin B12 levels, neurodegenerative disease, and cognitive impairment. The potential impact of comorbidities and medications associated with vitamin B12 derangements were also investigated. In addition, we reviewed the evidence as to whether vitamin B12 therapy is efficacious for cognitive impairment and dementia.Methods: A systematic literature search identified 43 studies investigating the association of vitamin B12 and cognitive impairment or dementia. Seventeen studies reported on the efficacy of vitamin B12 therapy for these conditions.Results: Vitamin B12 levels in the subclinical low-normal range (<250 ρmol/L) are associated with Alzheimer's disease, vascular dementia, and Parkinson's disease. Vegetarianism and metformin use contribute to depressed vitamin B12 levels and may independently increase the risk for cognitive impairment. Vitamin B12 deficiency (<150 ρmol/L) is associated with cognitive impairment. Vitamin B12 supplements administered orally or parenterally at high dose (1 mg daily) were effective in correcting biochemical deficiency, but improved cognition only in patients with pre-existing vitamin B12 deficiency (serum vitamin B12 levels 19.9 μmol/L).Conclusion: Low serum vitamin B12 levels are associated with neurodegenerative disease and cognitive impairment. There is a small subset of dementias that are reversible with vitamin B12 therapy and this treatment is inexpensive and safe. Vitamin B12 therapy does not improve cognition in patients without pre-existing deficiency. There is a need for large, well-resourced clinical trials to close the gaps in our current understanding of the nature of the associations of vitamin B12 insufficiency and neurodegenerative disease.

20 May 2014 in World Journal of Surgery
Verified
Journal Article
Closed access
DWDavid A. Watters
David A. Watters
MHMichael J. Hollands
Michael J. Hollands
RGRussell L. Gruen
Russell L. Gruen
KMKiki Maoate
Kiki Maoate
HPHaydn Perndt
Haydn Perndt
KMKelly A. McQueen
Kelly A. McQueen

29 October 2015 in Anz Journal of Surgery
Verified
Journal Article
Closed access
PDF file
WCWendy Crebbin
Wendy Crebbin
GCGraeme Campbell
Graeme Campbell
DHDavid A. Hillis
David A. Hillis
DWDavid A. Watters
David A. Watters

28 June 2007 in Anz Journal of Surgery
Verified
Journal Article
Closed access
PDF file
CYCheng‐Hon Yap
Cheng‐Hon Yap
MCMark E. Colson
Mark E. Colson
DWDavid A. Watters
David A. Watters

1 December 1992 in The American Journal of Surgery
Verified
Journal Article
Closed access
DWDavid A.K. Watters
David A.K. Watters
AAAnil T. Ahuja
Anil T. Ahuja
RERhodri M. Evans
Rhodri M. Evans
WCWilson Chick
Wilson Chick
WKWalter W.K. King
Walter W.K. King
ALArthur K.C. Li
Arthur K.C. Li

28 June 2016 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
KOKathleen M O'Neill
Kathleen M O'Neill
SGSarah L M Greenberg
Sarah L M Greenberg
MCMeena Cherian
Meena Cherian
RGRowan D Gillies
Rowan D Gillies
KDKimberly M Daniels
Kimberly M Daniels
RGRussell L Gruen
Russell L Gruen